Title: March 16th – FABS: French American Biotech Symposium
Location: The Salk Instittute for Biological Studies
Description: The FABS (French American Biotechnology Symposium) is a scientific seminar devoted to New Therapeutic and Vaccine Approaches to Infectious Diseases.

Start Time: 08:30 AM
Date: 2010-03-16

The objective is to promote cooperation in science and technology between the US and France.

The FABS event will be held at the Salk Institute, La Jolla (San Diego), California on March 16th 2010 and is co-organized by Lyonbiopole and the Office for Science and Technology of the French Consulate in Los Angeles in partnership with the Ubifrance Office in San Francisco, and French BIO beach in San Diego.

Who should attend?

o Academia & Principal Investigators
o Healthcare professionals
o Biotech company research officers

Program

o Presentations and panel discussions
o Morning Session : « Innovative Strategies in Vaccine Development »
o Afternoon Session : « Systems Biology and New Therapeutic Approaches »

For more information about the program and TO REGISTER, please click the link below:

http://www.metamorphoz.com/lyonbiopole/FABS/

Program 2010

Download the brochure in PDF

— 8.30 am — Registration

—8.50 am — Welcome Talks
Roger Guillemin – Distinguished Professor, Nobel Prize of Medicine – The Salk Institute for Biological Studies
David Martinon – Consul General of France in Los Angeles

—9.00 am to 12.30 — Session 1 / Vaccine Development: Innovative Strategies

Chairman :
Dennis Burton – Ph.D. – Professor in the Department of Immunology, The Scripps Research Institute

Dennis Burton – Ph.D. – Professor in the Department of Immunology, The Scripps Research Institute
Title: Neutralizing antibodies and an HIV vaccine
Marie-Joëlle Frachette – Ph.D. – Director External R&D, Sanofi Pasteur
Title: Adjuvanted Flu H1N1 Pandemic vaccine
Judit Szecsi – Ph.D. – EVIR, U758, INSERM
Title: DNA immunization with constructs coding for virus-like particles: New vaccination strategy against influenza A viruses
Greg Lemke – Professor – Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies
Title: TAM Receptors, Innate Immunity, and New Vaccine Adjuvants
Emmanuel Drouet – Professor at UVHCI UMR 5233 UJF-EMBL-CNRS – Grenoble
Title: A new approach for efficient vaccine development: the proteoliposome solution

Panel discussion

— Coffee break and networking

Chairman
Shane Crotty – Associate Professor – La Jolla Institute for Allergy and Immunology

Daniel Scott Algara – M.D., Ph.D., Associate Professor – Pasteur Institute
Title: Can we target NK cell subsets in order to obtain better vaccine and immunotherapy responses?
Nicolas Pasqual – Ph.D., President CEO & co-founder – ImmunID Technologies
Title: BCR&TCR combinatorial repertoire diversity : a promising biomarker of treatment efficiency/risk ratio
Vaughn Smider – M.D., Ph.D., Founder & CEO – Fabrus LLC
Title: Spatially addressed antibody libraries to discover novel activities
Frédéric Legros – Ph.D. – Business Development Manager, Vivalis
Title: The EB66 cell line: A enhanced solution for the production of biologics
Nathalie Mielcarek – Ph.D., Scientist – Pasteur Institute of Lille
Title: Live attenuated Bordetella pertussis as a single-dose nasal vaccine against whooping-cough

Panel discussion

—1.00 pm Lunch Break

—2.00 pm to 6.00 pm — Session 2 – Systems Biology and New Therapeutic Approaches
Chairman : Christian Bréchot – Vice President for medical and scientific affairs – Institut Mérieux

Sumit Chanda – Ph.D., Associate Professor – Sanford Burnham Research Institute
Title: Systems based approaches to identifying viral host-pathogen interactions
Suzana Salcedo – Ph.D. – Immunology Centre of Marseille Lumigny, INSERM
Title: Understanding how Brucella manipulates and hides within host cells: clues for new therapeutic and vaccine approaches
Nevan Krogan – Assistant professor – Department of Cellular and Molecular Pharmacology UC San Francisco (UCSF)
Title: Functional insights from protein-protein & genetic interaction maps
Pablo Gluschankof – Ph.D., President & Scientific Director – Amikana Biologics
Title: Phenotyping HIV resistance through yeast
Marianne Manchester – Ph.D., Professor – Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego
Title: Characterizing infection & inflammation by metabolomics

Panel discussion

— Coffee break and networking

Chairman :
John Young – Ph.D., Professor at the Salk Institute For Biological Studies – La Jolla, CA, USA.

Victor Nizet – Professor of Pediatrics & Pharmacy – University of California, San Diego (UCSD)
Title: Two “Outside the Box” Approaches to Staphylococcus aureus Therapy
Philippe Afonso – Ph.D. – National Health Institute
Title: highly active antiretroviral treatment against HTLV-1/STLV-1 infection combining reverse transcriptase and HDAC inhibitors
Elizabeth Winzeler – Department Head of the Genomics Institute – The Novartis Research Foundation
Title: Using systems biology to discover new drugs for malaria
Thomas Baumert – PhD., Professor – University of Strasbourg, INSERM, Hopitaux de Strasbourg
Title: Novel antiviral preventive and therapeutic strategies targeting hepatitis C virus entry

Panel discussion

Keynote Speaker for the conclusive session: Dominique Charron – M.D., Ph.D., Director – UMRS 940 INSERM, IUH, Hôpital Saint-Louis, Professor of Immunology, University of Paris-Diderot, Head Immunology / Histocompatibility Department – AP-HP, Hopital Saint-Louis, Paris INSERM UMRS 940
Title: Immunity & allogeneicity in stem cell therapy

— 6.00 pm Networking reception

———–
Lyonbiopôle
Contacts: Isabelle Scarabin & Kevin Romani
Isabelle.scarabin@lyonbiopole.com
kevin.romani@lyonbiopole.com

French Consulate in Los Angeles – Office of Science and Technology
Contacts: Mireille Guyader & Thomas Biedermann
attache-sdv.mst@consulfrance-losangeles.org
deputy-sdv.mst@consulfrance-losangeles.org

French BioBeach
Contact: Stephane Richard
srichard@frenchbiobeach.com
———–

For more information about the program and TO REGISTER, please click the link below:

http://www.metamorphoz.com/lyonbiopole/FABS/

FABS 2010 >>> List of attendees as of 03/05/2010

Pr Baverel Gabriel (METABOLYS)
Dr Bhattacharyya Suchita (Salk Institute for Biological Studies)
Bres Vanessa (The Salk Institute)
Dr Charusanti Pep (University of California, San Diego)
Dr Cho Helen (Pfizer)
Dr CLEUZIAT Philippe (INSTITUT MERIEUX)
Dr Coetzer Mia (The Scripps Research Institute)
Dr Corbeil Lynette (University of California, San Diego)
Ms Craig-Kennard Adrienne (Genostar)
Dr Dias Alexandre (PX’Therapeutics)
Ms Feau Sonia (La Jolla Institute for Allergy and Immunology)
Dr Gabard Jérôme (Pherecydes Pharma)
Pr Griffin John (Scripps Research Institute)
Guo Joan (Pfizer)
Dr Hanania Elie (SAFC Carlsbad)
Dr Hartikka Jukka (Vical Incorporated)
Dr Jamois Eric (Prestwick Chemical Inc.)
Kinkead Heather (The Scripps Research Institute)
Dr Lambert Bill (Pacira Pharmaceuticals)
Law Mansun (The Scripps Research Institute)
Dr Le Calvez Herve (ABBIOTEC)
Dr Lu Wendell (University of California San Diego)
Dr Morfin Eric (BioPharmaPM)
Dr Mosier Donald (The Scripps Research Institute)
Ms Plantier Nadia (ImmunID Technologies)
Dr Ponts Nadia (UC Riverside)
Ms Rehbinder Sharon (AEPI Grenoble-Isere France)
Dr Rolland Alain (Vical incorporated)
Dr Schaeffer James (Merck & Co., Inc.)
Dr Sullivan Sean (Vical, Inc.)
Ms Tanneau Isabelle (Ubifrance – French Trade Office)
Pr Teyton Luc (TSRI)
Dr Tucker John (Katan Associates)
Dr zelar andrew (Biologics Consulting Group)

Related posts:

1. March 15th – FBT: French Biotech Tour California
2. French-American Biotech & BIO BIZ Symposiums (FABS & FABZ) on “New therapeutical and vaccine approaches in infectious diseases” – April 2nd & 3rd 2008
3. April 2nd & 3rd 2008 – French-American Biotech & BIO BIZ Symposiums (FABS & FABZ)
4. French Bio Beach January 26th Event: “Development of Toxicology / Ecotoxicology: New European Regulations, New Business Opportunities”
5. FABS 2009 – March 30 & 31 Lyon France